User menu

Influence of 16-beta-formylation On Na, K-atpase Inhibition By Cardiac-glycosides

Bibliographic reference Depover, A. ; Godfraind, Theophile. Influence of 16-beta-formylation On Na, K-atpase Inhibition By Cardiac-glycosides. In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 321, no. 2, p. 135-139 (1982)
Permanent URL
  1. Clarck AF, Swanson PD, Stahl WL (1975) Increase in dissociation rate constants of cardiotonic steroid-brain (Na++K+)-ATPase complexes by reduction of the unsaturated lactone. J Biol Chem 250:9355?9359
  2. De Pover A, Godfraind T (1979) Interaction of ouabain with (Na++K+)-ATPase preparations from human heart and guinea-pig heart. Biochem Pharmacol 28:3051?3056
  3. Dolphen R, Lesne M (1980) Uptake and pharmacological effect of gitoxin and gitaloxin in rat and guinea-pig perfused hearts. Arzneim-Forsch (Drug Res) 30:614?618
  4. Erdmann E, Schoner W (1974) Ouabain-receptor interactions in (Na++K+)-ATPase preparations. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. Naunyn-Schmiedeberg's Arch Pharmacol 283:335?356
  5. Georges A (1967) Les hétérosides cardiotoniques de la digitale et leurs dérivés semi-synthétiques. Ed Arscia, Brussels
  6. Godfraind T, De Pover A, Verbeke N (1977) Influence of pH and sodium on the inhibition of gunea-pig heart (Na++K+)-ATPase by calcium. Biochim Biophys Acta 481:202?211
  7. Godfraind T, Ghysel-Burton J (1980) Independence of the positive inotropic effect of ouabain from the inhibition of the heart Na-K pump. Proc Natl Acad Sci USA 77:3067?3069
  8. Godfraind T, Tona Lutete D (1979) Inhibition by digoxin and SC4453 of (Na++K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain. Eur J Pharmacol 60:329?336
  9. Güntert TW, Linde HHA (1981) Chemistry and structure-activity relationships of cardioactive steroids. Handb Exp Pharmacol 56/1:13?24
  10. Hunter A, Downs CE (1945) The inhibition, of arginase by amino acids. J Biol Chem 157:427?446
  11. Korolkovas A (1970) Essentials of molecular pharmacology. Background for drug design. Wiley-Interscience, New York
  12. Langer GA (1981) Mechanism of action of the cardiac glycosides on the heart. Biochem Pharmacol 30:3261?3264
  13. Lingner K, Küssner W (1962) Resorption und Abbau herzwirksamer Glykoside. Mitteilung: Abbau von Cardenolidglykosiden in vitro. Arzneim Forsch 12:835?841
  14. Naaido BK, Witty TR, Remers WA, Besch HR Jr (1974) Cardiotonic steroids. Improtance of 14?-hydroxy group in digitoxigenin. J Pharm Sci 63:1391?1394
  15. Portius HJ, Repke K (1964) Versuch einer Analyse der Beziehungen zwischen chemischer Struktur und digitalisähnlicher Wirksamkeit auf der Rezeptorebene. Arzneim-Forsch (Drug Res) 14:1073?1077
  16. Schwartz A, Lindenmayer GE, Allen JC (1975) The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects. Pharmacol Rev 27:1?134
  17. Thomas R, Boutagy J, Gelbart A (1974) Synthesis and biological activity of semisynthetic digitalis analogs. J Pharm Sci 63:1649?1683
  18. Thomas R, Allen JC, Pitts BJ Jr, Schwartz A (1979) Cardenolide analogs. An explanation for the unusual properties of AY 22241. Eur J Pharmacol 53:227?237
  19. Wilson WE, Sivitz WI, Hanna LT (1970) Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model Mol Pharmacol 6:449?459
  20. Yoda A (1973) Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. Dissociation rate constants of various enzymecardiac glycoside complexes formed in the presence of magnesium and phosphate. Mol Pharmacol 9:51?60
  21. Yoda A, Yoda S (1980) The interaction of ouabagenum and (Na++K+)-ATPase in the presence of Na+, Mg+ and ATP. Mol Pharmacol 19:62?67